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Abstract:
Cell heterogeneity and the inherent complexity due to the interplay of multiple molecular 
processes within the cell pose difficult challenges for current single-cell biology. We 
introduce an approach that identifies a disease phenotype from multiparameter single-
cell measurements, which is based on the concept of “supercell statistics”, a single-cell-
based averaging procedure followed by  a machine learning classification scheme. We 
are able to assess the optimal tradeoff between the number of single cells averaged 
and the number of measurements needed to capture phenotypic differences between 
healthy and diseased patients, as well as between different diseases that are difficult to 
diagnose otherwise. We apply our approach to two kinds of single-cell datasets, 
addressing the diagnosis of a premature aging disorder using images of cell nuclei, as 
well as the phenotypes of two non-infectious uveitides (the ocular manifestations of 
Behçetʼs disease and sarcoidosis) based on multicolor flow cytometry. In the former 
case, one nuclear shape measurement taken over a group  of 30 cells is sufficient to 
classify samples as healthy or diseased, in agreement with usual laboratory practice. In 
the latter, our method is able to identify a minimal set of 5 markers that accurately 
predict Behçetʼs disease and sarcoidosis. This is the first time that a quantitative 
phenotypic distinction between these two diseases has been achieved. To obtain this 
clear phenotypic signature, about one hundred CD8+ T cells need to be measured. 
Although the molecular markers identified have been reported to be important players in 
autoimmune disorders, this is the first report pointing out that CD8+ T cells can be used 
to distinguish two systemic inflammatory diseases. Beyond these specific cases, the 
approach proposed here is applicable to datasets generated by other kinds of state-of-
the-art and forthcoming single-cell technologies, such as multidimensional mass 
cytometry, single-cell gene expression, and single-cell full genome sequencing 
techniques.  
Author Summary:
The behavior of organisms is based on the concerted action occurring on an 
astonishing range of scales from the molecular to the organismal level. Molecular 
properties control the function of a cell, while cell ensembles form tissues and organs, 
which work together as an organism. In order to understand and characterize the 
molecular nature of the emergent properties of a cell, it is essential that multiple 
components of the cell are measured simultaneously in the same cell. Similarly, multiple 
cells must be measured in order to understand health and disease in the organism. In 
this work, we develop an approach that is able to determine how many cells, how many 
measurements per cell, and which measurements are needed to reliably  diagnose 
disease. We apply  this method to two different problems: the diagnosis of a premature 
aging disorder using images of cell nuclei, and the distinction between two similar 
autoimmune eye diseases using stained cells from patientsʼ blood samples. Our 
findings shed new light on the role of specific kinds of immune system cells in systemic 
inflammatory diseases and may lead to improved diagnosis and treatment. 
Introduction 
In the life sciences, there is now a wealth of quantitative information from simultaneous 
measurements on many proteins and genes, from small tissue samples down to a 
single cell at a time [1-6]. Likewise, bioimaging is following a similar trend through 
multicolor fluorescent imaging and the emerging ability to carry out spatially  resolved 
vibrational spectroscopy of living cells in close to real-time [7,8]. These groundbreaking 
technologies have resulted in a plethora of information for single cells, which can be 
represented as points in a high-dimensional space. Here we show how one can tease 
out the essential information from such high-dimensional data in order to diagnose 
human diseases and understand their molecular origins.  
Our approach tackles two interlinked challenges inherent to high-dimensional, single-
cell information. First, single-cell measurements exhibit vast heterogeneity in the 
behavior of individual cells: even a simple bell-shaped distribution can contain 
subpopulations enriched for biologically distinct functions. For instance, subpopulations 
of clonally  derived hematopoietic progenitor cells with low or high expression of the 
stem cell marker Sca-1 were observed to be in dramatically different transcriptional 
states and to give rise to different blood cell lineages [9]. Second, cell phenotypes are 
emergent products of multiple molecular actions: the phenotype of a tissue or organism 
often requires not only  multiple cells, but also multiple attributes at the cellular level, 
which makes bridging scales from molecular and cellular level information to disease 
diagnosis a challenging, oftentimes elusive goal [10].       
Here we present a new approach to analyze high-dimensional single-cell information, 
and apply it to two representative datasets. We address the diagnosis of progeria, a 
premature aging disorder [11], where single-cell data are obtained by  an automated 
nuclear shape analysis from hundreds of healthy and diseased cells. We also develop a 
multiparameter phenotype in order to distinguish two sight threatening non-infectious 
uveitides, the ocular manifestations of Behçetʼs disease and sarcoidosis, based on 
multicolor flow cytometry information on tens of proteins from fresh blood patient 
samples. Our emphasis is to assess the optimal tradeoff between the number of single 
cells averaged and the number of measurements needed to capture phenotypic 
difference. The number of available cells may be a key  limiting factor when target cell 
subpopulations are extremely small (e.g. hematopoietic stem cells from bone marrow or 
blood samples) or when the experimental techniques are not easily scalable (e.g. 
single-cell imaging and single-cell gene expression). 
In the next Section, we describe some common approaches to analyze 
multidimensional single-cell datasets, we show their shortcomings due to cell 
heterogeneity  and the inherent multidimensional nature implied in a complex phenotype, 
and we apply our approach to the two specific cases mentioned above. In the following 
Section, we provide a summary and a discussion of our findings.  
Results
A commonly used method to visualize and analyze multidimensional single cell 
information is through sequential selection of subtypes of cells based on simple 
thresholds, applied to one or two parameters at a time [12]. This procedure is generally 
represented as a sequence of two-dimensional plots, where one attribute is plotted 
against another one.  This method works extremely well when simple thresholds for just 
a few parameters lead to reliable phenotypes.  However, for complex diseases such as 
Behçetʼs and sarcoidosis, even the best choice of parameters is not enough to identify a 
phenotype. A representative example is shown in Fig. 1A(i): CD8+ T cells have very 
similar combinations of IL22 and CD3 levels in both Behçetʼs disease and sarcoidosis, 
even though – as we will show below – these parameters play a key  role in 
distinguishing between the two diseases. Similarly, highly  overlapping populations are 
observed for other cell types we investigated (e.g. CD4+ T cells) and other pairs of 
markers studied. This indicates that the distinction between Behçetʼs disease and 
sarcoidosis can only be discerned using a combination of more than two parameters, 
and thus is difficult to visualize and detect with established approaches.  
Going beyond two parameters, some mathematical tools are able to reduce the 
dimensionality of high-dimensional data [13,14]. Singular value decomposition is a 
simple, yet powerful technique for generating low dimensional representations [13]. 
However, the optimal axes selected by  such a method are not designed to distinguish 
between health and disease, or help  diagnose the disease. This is evident in Fig. 1A(ii), 
where the two top  eigenmodes from a singular-value decomposition analysis of 16-
dimensional data are plotted for the same CD8+ T cell subpopulation, showing again a 
large overlap between the two diseases.   
Even in cases where a single parameter can be established as a suitable phenotype, 
cell-to-cell heterogeneity presents a challenge. For example, in Hutchinson-Gilford 
progeria syndrome (HGPS), a rare genetic disease of accelerated aging, the number of 
“blebs” or localized protrusions visible in a cellʼs nucleus is an established cellular 
marker of HGPS [15]. However, that does not imply  that a single cell showing blebs 
indicates HGPS. Instead, as shown by Fig. 1B(i)-(iv), blebbed and non-blebbed nuclei 
are observed both within healthy and diseased cell lines. On average, nevertheless, 
blebbing is a reliable phenotype, as illustrated in Fig. 1B(v)-(vi). This raises the 
question: can one simply measure other aspects of the nuclear shape with additional 
metrics to establish a disease phenotype from a single cell, or does cell heterogeneity 
require us to investigate the properties of cell ensembles for a reliable diagnosis?  The 
tradeoff between multidimensional measurements and the number of cells needed to 
achieve a desired confidence level of prediction certainly  requires an unbiased, fully 
quantitative, and mathematically robust method.      
Here we introduce and apply an approach to develop  a disease phenotype from 
multiparameter single-cell measurements. Our approach uses simple machine learning 
methods to determine what combination of parameters can serve as an indicator of 
disease, and how many parameters are needed to diagnose a disease.  While machine 
learning of disease diagnostics is not new, it often fails when applied at the single-cell 
level due to the heterogeneity  of cells. It also fails when average quantities are 
measured if the number of patients is not large enough for a machine learning 
approach. The simple additional step  of averaging over a small number of cells - here 
tens to hundreds of cells – and varying that number allows us to optimize our ability to 
detect a disease phenotype. This procedure smoothes out single cell heterogeneity and, 
at the same time, minimizes the loss of information due to averaging. For machine 
learning purposes, each patient is still represented by  a point cloud in parameter space, 
but now each point represents a group of cells, rather than an individual cell.
Recently, several groups have developed computational methods for identifying cell 
populations in multidimensional flow cytometry data. Their goals are two-fold: on the 
one hand, to determine whether automated algorithms can reproduce expert manual 
gating; on the other hand, to determine whether analysis pipelines can identify 
characteristics that correlate with external variables such as clinical outcome. In the 
latter case, flow cytometry data is transformed into class-labeled vectors in instance 
space by a variety of methods such as binning of 2D and 3D measurement histograms, 
Gaussian mixtures, 1D and sequential gating schemes, and cell clustering using k-
means and other high-dimensional clustering techniques [16-23]. A detailed description 
and comparative assessment of the performance of different approaches has been 
recently reported [24]. Within this context, it is important to point out that the method 
proposed in our work addresses the problem of phenotypic classification when single 
cells are highly heterogeneous and when the number of cells available may be rather 
small (just a few tens or hundreds, as opposed to typical flow cytometry  experiments in 
which the number of measured cells is one or several orders of magnitude larger). We 
will demonstrate that our method is generally applicable to different kinds of 
multidimensional single-cell data and one of our examples is on flow- cytometry-based 
phenotypes. However, the key contribution is the development of a framework that 
provides a quantitative assessment of the critical sample size and number of 
simultaneous single-cell measurements needed to identify a phenotype with strong 
predictive power. State-of-the-art single-cell genomics and single-cell imaging 
technologies are examples in which the number of measured  single cells is critically 
small, and where flow cytometry data analysis methods that rely on high-dimensional 
clustering procedures, Gaussian mixture approximations, etc may be expected to fail. 
We will tackle the tradeoff between the number of parameters and the number of cells 
needed first on the example of HGPS - the mathematics are the same for any 
multidimensional single-cell dataset. A complete approach would entail the study of the 
distribution of the individual measurement vectors. Our results demonstrate, a 
posteriori, that simple averages suffice for carrying out the calculations successfully. We 
define a “supercell of size N” as the average of the individual measurement vectors of N 
randomly selected cells. By  repeatedly taking different random subsets of N cells from 
the original datasets, we build “supercell samples” and we are thus able to compute 
“supercell statistics”. This procedure is illustrated in Fig. 2A(i)-(ii), where we select one 
shape parameter (namely, the number of invaginations of the nuclear boundary) and 
compute the probability density distributions for healthy and diseased cell lines. In Fig. 
2A(i), the distributions for single cells are highly  overlapping, reflecting the fact that, 
based on individual cells, one is not able to distinguish healthy cells from diseased ones 
(SI Dataset S1). After applying the cell averaging procedure (using N=30 randomly 
selected cells to generate each “supercell”), we obtain distributions without any 
significant overlap  between healthy  and diseased samples, as shown by Fig. 2A(ii). The 
supercell size N=30 has been chosen because it represents the smallest size that 
provides a full separation between healthy  and diseased samples, regardless of the 
number of parameters used (see discussion below). 
The removal of distribution overlaps is a manifestation of the central limit theorem (CLT) 
of probability  theory [25-27]. The CLT states that, given a set of n independent random 
variables associated with arbitrary  probability  distributions with finite mean μi and 
variance σi2 (for i=1,2,...,n), their average is a random variable whose asymptotic 
cumulative distribution function approaches a normal distribution with mean μ = ∑μi/n 
and variance σ2 = (∑σi2/n)/n. As a consequence, distributions of supercells of size N are 
expected to become narrower by a factor of ~1/√N. For instance, comparing Fig. 2A(i) 
with Fig. 2A(ii), we observe that the width of the latter is approximately smaller by a 
factor of ~1/√30≈0.2. Another consequence of the CLT is that the shape of supercell 
distributions becomes closer to Gaussian as N is increased. It should be pointed out 
that the supercell framework does not rely on a priori assumptions regarding the shape 
of the measurement distributions. On the contrary, it incorporates all features of the 
original distributions, thus naturally dealing with issues such as skewed distributions 
with regions that could be ambiguously  attributed to outliers or to poorly resolved 
subpopulations. However, if the measurement distributions are distinctly  multimodal due 
to well-defined cell subpopulations, then the ability to predict reliable phenotypes might 
be compromised. In such a scenario, robust phenotyping might first require the 
identification of different cell subpopulations followed by the application of the supercell 
framework separately to each of them. This procedure is discussed below in the context 
of distinguishing healthy individuals from patients with two non-infectious uveitides by 
using either all cells from peripheral blood samples, or different T cell subpopulations 
(see Fig. 3). 
After cell averaging, machine learning allows us to learn what combination of 
parameters best distinguishes healthy from diseased cells. In order to avoid overfitting 
and also to obtain a straightforward interpretation of the machine-learned parameters in 
terms of the original measurements, we used a support vector machine with a linear 
kernel, which is equivalent to the machine learning method known as the perceptron 
[28,29]. Healthy and HGPS nuclear shapes were characterized by 12 parameters 
including eccentricity, number of invaginations, minor/major axis length, mean and 
standard deviation of the curvature, and perimeter. Moreover, the concentration of lamin 
A/C (measured based on the fluorescence signals of lamin A/C) was represented 
through 3 additional parameters for each nucleus. However, for single cells, even with 
these 15 parameters, the distinction between individual cells from healthy and diseased 
cell lines is not learnable. Fig. 2B(i) shows the distance from each cell to the perceptron 
boundary, where positive (negative) distances correspond to the boundary side 
identified with the healthy (diseased) class. We observe that some cells from the 
healthy cell lines are classified as diseased, and vice versa. Instead, machine learning 
applied to the supercell samples works with 100% accuracy, as displayed in Fig. 2B(ii).
 
The questions arise, then, which and how many parameters are needed to achieve a 
classification of desired accuracy, and how many cells need to be averaged into a 
“supercell”. Fig. 2C(i) shows the perceptron amplitudes (i.e., the components of the 
vector normal to the boundary hyperplane) for each of the 15 parameters. A positive 
sign indicates that a given parameter is higher in healthy cells relative to diseased cells, 
while its absolute value is a measure of its overall significance (relative to the other 
parameters) in separating healthy cells from diseased ones. Therefore, we can rank-
order the 15 parameters from most to least relevant according to their decreasing 
amplitudes (in absolute values), and learn using just the top M parameters from the 
rank-ordered list. While this rank ordering is independent of supercell size for large 
supercells, it it is very different from the rank ordering for single cells (if the single cell 
measurements are strongly overlapping). Indeed, sizable fluctuations are observed in 
the single-cell and small-supercell regime (up  to supercells of size ~10) followed by a 
stable rank-order for larger supercell sizes. The fraction of cells correctly  classified by 
the machine learning process as a function of the supercell size is shown in Fig. 2C(ii). 
The different curves represent different numbers of parameters (M). As expected, the 
classification accuracy increases with both M and the supercell size. While a single cell 
is not sufficient for classification, a single parameter (the number of invaginations) is 
sufficient for correct classification of HGPS. Indeed, this is consistent with the standard 
approach to assess the disease states of HGPS based on visual analysis (i.e. the 
detection of “blebs”) and indicates that the invaginations are the most distinguishing 
features of blebs [30-32].        
 
In our second example, we apply our technique first to the simpler problem of 
distinguishing healthy individuals from patients with two non-infectious uveitides, and 
then to the formidable challenge of distinguishing Behçetʼs disease from sarcoidosis. 
Recent work has reported progress in the ability to pinpoint molecular indicators for 
inflammatory immune diseases, where larger-than-normal levels of a novel subset of 
effector memory CD4+ T lymphocytes expressing the endothelial adhesion molecule 
CD146 have been observed in sarcoidosis, Behçetʼs, and Crohnʼs disease [33]. 
However, while patients can be diagnosed with Behçetʼs disease or sarcoidosis based 
on the concurrent observation of a number of clinical indicators, molecular signatures 
unique to these diseases have not been found. Our analysis of a molecular phenotype 
uses flow cytometry experiments, in which 14 molecular markers previously  reported on 
human CD4+ and/or CD8+ T cells were measured for each cell; additionally, forward- 
(FSC) and side-scattering (SSC) measures were also taken on each cell. Thus, a total 
of 16 simultaneous measurements were performed on each cell from patientsʼ 
peripheral blood, with about one million cells measured per patient. From a cohort of 22 
patients, 7 were diagnosed with sarcoidosis, 6 with Behçetʼs disease, 1 with retinal 
vasculitis, while the remaining 8 were healthy controls. We start with large supercells to 
assess whether molecular phenotyping is possible at all to distinguish sarcoidosis and 
Behçetʼs disease.  We represent each patient sample with 100 supercells, where each 
supercell was obtained from averages over 500 randomly chosen cells. We carry out 
separate analyses for the distinction between healthy and diseased patients (Fig. 3(a)-
(c)), and for the separation between the two diseases sarcoidosis and Behçetʼs (Fig. 3
(d)-(f)). Furthermore, we perform separate analyses for all cells (SI Dataset S2), for 
CD4+ T cells (that can be isolated using standard gating procedures based on the 
sequence viability-/CD3+/CD4+/CD8-) (SI Dataset S3) and for CD8+ T cells (similarly 
identified according to viability-/CD3+/CD8+/CD4-) (SI Dataset S4). 
Because we have a larger number of patients than we did for HGPS, we can directly 
assess the predictive power of our approach to correctly diagnose a new patient.  We 
tested the predictive power of our learnt patterns using a standard data-resampling 
method, namely the so-called jackknife procedure: leaving out one patient at a time, one 
learns with the remaining data and makes a prediction on the test patient [34]. In that 
way, one can determine the percentage of correct and failed predictions. Since each 
patient is represented by a cloud of 100 supercells, it may happen that the perceptron 
boundary cuts across the test patientʼs supercell cloud. We set a threshold of 95% in 
order to make a prediction: e.g. if the supercell cloud is more than 95% consistent with 
sarcoidosis, we classify the patient as having sarcoidosis.  If the supercell cloud falls on 
the boundary between diagnoses (i.e. with less that 95% of the supercells on either side 
of the perceptron boundary), we leave the test patient unclassified. Naturally, setting the 
prediction threshold to lower values leads to less unclassified patients, but tends to 
increase the number of failed predictions; in contrast, increasing the threshold to higher 
values leads to a more conservative approach, where the number of failed predictions is 
smaller at the expense of a larger number of unclassified patients. By  changing the 
prediction threshold values over the range between 80% and 100%, the observed 
variations of the predicted outcome were below 10% of the cohort; the method is thus 
largely insensitive to the choice of the threshold parameter.  
By learning using all available measures, we are able to rank-order the importance of 
the measures based on the perceptron amplitudes. The ten most important measures 
and corresponding amplitudes are listed in Fig. 3(a)-(f). The percentage of patients 
correctly predicted (green), unclassified (blue), and incorrectly predicted (red) are 
shown as a function of the number of rank-ordered measures used. The outcomes 
depend strongly  on the type of cells used: for the “healthy vs diseased” case, no 
incorrect predictions are made using all cells and just the top  two measures, namely 
viability and CD197 (Fig. 3(a)). The predictions are even stronger if using only  CD4+ T 
cells, since the top  marker (CD27) is sufficient by itself to correctly classify all healthy 
patients (with high frequency of CD4+CD27+ T cells in their peripheral blood) and all 
diseased patients (with low frequency of CD4+CD27+ T cells in their peripheral blood) in 
the cohort (Fig. 3(b)). In contrast, failed predictions are seen for the case of CD8+ T 
cells, irrespective of the number of measures used (Fig. 3(c)). Previous reports have 
suggested that CD4+CD27+ T cells represent the majority  of natural regulatory  T cells in 
human peripheral blood [35]. Thus, our results indicate that patients with either Behcetʼs 
disease or Sarcoidosis have low frequency of peripheral natural regulatory T cells and, 
therefore, potentially compromised immunoregulatory functions during inflammatory 
responses. 
In order to separate Behçetʼs disease and sarcoidosis, predictions based on all cells are 
very  poor (Fig. 3(d)), better for CD4+ T cells (Fig. 3(e)) and best for CD8+ T cells (Fig. 3
(f)), for which no failed predictions are made when five or more measures are used. 
This result indicates that the top measures listed in Fig. 3(f) may be used as molecular 
phenotypes that distinguish the two diseases. This is, to the best of our knowledge, the 
first report pointing out that CD8+ T cells can be used to distinguish two systemic 
inflammatory diseases. Moreover, it is interesting to note that, in distinguishing between 
patients with ocular inflammation and controls without it, the CD4 marker was an 
important feature, while for distinguishing between the ocular manifestations of two 
systemic disorders, the CD8 cell marker was superior.
Given our success in demonstrating the power of molecular phenotyping to distinguish 
the diseases, we turn now to the analysis of the balance between the number of cells 
we need to average, and the number of molecular markers we need to measure. For 
the “healthy vs diseased” case using CD4+ T cells, the percentage of correctly classified 
supercells is shown in Fig. 3(g) as a function of the supercell size and the number of 
measures used. Note that for single cells, the classification performance is very poor 
even using many measures, but averaging over more than ten cells is sufficient for 
reliable classification if a large number of measures is used. In contrast, just one 
measured marker is sufficient provided that we average over 100+ cells. This fact is 
underscored in Fig. 3(h), where the intensity distribution for supercells of size 500 are 
shown separately  for the healthy and the diseased patients, using just the top marker 
(CD27). The dashed line indicates the marker intensity  threshold that allows a complete 
separation of the two classes of supercells. The “sarcoidosis vs Behçetʼs” classification 
is further studied in Fig. 3(i) for CD8+ T cells, where the percentage of correctly 
classified supercells is shown as a function of the supercell size and the number of 
measures used. We find that slightly less than 100 cells are sufficient for reliable 
classification, as long as the top five markers are measured.  Increasing the number of 
markers or averaging over more cells does not strongly  change the reliability of the 
classification.  Finally, the ability to classify Behçetʼs disease vs sarcoidosis when using 
the top  5 markers is visualized in a new way in Fig. 3(j). The visualization is derived 
from the identification of patterns in two-dimensional parameter space (Fig. 1A(i)), which 
has proven to be a tremendously successful tool for the analysis of low-dimensional 
data in flow cytometry.  The combined approach of cell averaging into supercells, 
followed by machine learning, allows us to find the correct linear combinations of 
markers needed to fully separate the two diseases (Fig. 3(j)). In geometrical terms, we 
learned that only 5 dimensions (out of the original 16) are needed; moreover, we 
determined the preferred direction that maximizes the gradient between the “sarcoidosis 
class” and the “Behçetʼs disease class”. This optimal class separation was achieved by 
means of an unbiased, mathematically robust method: no additional biological 
information was needed to proceed from Fig. 1A(i) to Fig. 3(j). 
Discussion
We present a simple approach to quantify disease phenotypes based on single cell 
measurements with multiple parameters measured on each cell.  For our study of 
autoimmune diseases, we measure 16 parameters for millions of cells with flow 
cytometry, and use this information to find a molecular phenotype of Behçetʼs disease. 
We also measure 15 parameters from hundreds of fluorescence images obtained via 
microscopy, and use this information to automate classification of HGPS. Our data span 
many more dimensions than the traditional two parameters used for visually-aided cell 
classification (Fig. 1A). We use machine learning, which allows for a reproducible, 
objective, and automated approach to find the optimal boundary  between two high- 
dimensional classes of data points. The question we tackle is straightforward: do we 
obtain more information about a disease by the analysis of more cells, or by measuring 
more parameters on each cell?
The key to our novel approach is to introduce variable size cell groups (“supercells”), 
with the group  size as an explicit parameter that we vary systematically. This reveals the 
number of cells that need to be grouped in order to obtain a robust disease 
classification. We also determine to what degree adding parameters reduces the 
number of cells needed to determine a phenotype.  
 
Our approach to separate cell groups relies on a machine learning classification 
method. It is tailored specifically to determine the most useful combination of 
parameters to distinguish among all cells or cell groups rather than finding the optimal 
low-dimensional representation, as in singular value decomposition or principal 
component analysis. This procedure is schematically illustrated in Fig. 4, where 
synthetic 2D datasets were generated to represent patient samples classified in two 
categories: 4 samples correspond to “Class A”, while the remaining 3 samples are 
labeled “Class B”. At the single-cell level, the data are non-separable due to cell 
heterogeneity  (Fig. 4(a)). A machine learning classifier such as support vector machines 
with a linear kernel (Fig. 4(b)) can be implemented in order to find the optimal decision 
boundary between the two classes; however, this method requires the data to be 
separable. More sophisticated variants, such as soft margin classifiers and nonlinear 
classifiers can be designed to learn from non-separable data, even in strongly 
overlapping cases such as those usually  encountered in single-cell datasets (see e.g. 
Fig. 1A(i)).  However, our analysis shows that the optimal “boundary” inferred from 
overlapping distributions is distinct from the boundary obtained from supercells which 
actually  has predictive power for phenotyping: the weight of parameters is very different 
for single cells and supercells whose distribution is well separated.  In order to avoid 
overlapping patient samples, one could characterize each of them by the moments of 
the cell multivariate distributions, the simplest example being the sample means (Fig. 4
(c)). This approach, however, lacks robustness:  the decision boundaries are very 
sensitive to nearby datapoints, in particular to the support vectors that determine the 
classification hyperplanes, thus leading to failed predictions. Supercell distributions are 
built by averaging over groups of single cells. By applying machine learning on supercell 
samples, a robust class separation is achieved (Fig. 4(d)). 
 
In HGPS, our approach confirms the current practice that the number of invaginations 
(or mean negative curvature) is the most valuable nuclear metrics for phenotyping the 
disease using nuclear images. Importantly, we find that when analyzing 30 cells or 
more, a robust phenotype can be obtained simply  based on the invaginations of each 
cell, and a more in depth analysis of additional nuclear shape metrics does not 
significantly reduce the number of cells needed. Our findings provide a principle 
guideline of the minimal cell numbers used in future disease assessments and high-
throughput drug screenings of age-related diseases, in which abnormal nuclear shape 
is considered a hallmark phenotype. This information is of extreme importance in a rare 
disease like HGPS with very limited availability of patient samples.
In our second example, we apply our technique to distinguish healthy individuals from 
patients with two non-infectious uveitides, and among those patients we distinguish 
between Behçetʼs disease and sarcoidosis. In order to distinguish healthy from disease 
phenotypes, we found that within the CD4+ T cell subpopulation, just one marker was 
enough (Fig. 3(b)). Indeed, CD27 appears consistently overexpressed in healthy 
samples (Fig. 3(h)). The ability to predict healthy and diseased phenotypes based on 
CD4+ T (super)cells is resilient under the removal of the top  markers: even by removing 
the top 7 markers from the list, we are still able to classify patients as healthy or 
diseased with no failures. In contrast, CD8+ T cells do not have a clear distinction 
between healthy  and diseased conditions, even using all markers available from the 
flow cytometry experiment (Fig.3 (c)). However, by focusing specifically  on sarcoidosis 
and Behçetʼs disease, we demonstrate a robust means of predicting a patientʼs 
diagnosis based on 5 optimally chosen markers using CD8+ T (super)cells (Fig. 3(f)). If 
the top marker (IL22) is removed from the list, incorrect predictions are observed even 
using all remaining markers; therefore, phenotyping sarcoidosis vs Behçetʼs is 
inherently high-dimensional (since it requires at least 5 markers to be accurate) and 
also very specific to those markers. An important evaluation for the future will be to 
evaluate the efficacy of these markers in patients with these two systemic disorders who 
do not have ocular complications of their disease, i.e. whether these findings are 
specific to the ocular disorder, or a reflection of the systemic disorder itself. By using a 
precise linear combination of IL22, CD3, viability, CD8 and CD62L, we are able to 
separate the two diseases successfully  based on molecular markers (Fig. 3(j)). 
Averages of hundreds of cells are required for this phenotyping, and increasing the 
number of measured parameters does not reduce the number of cells required. The 
molecular markers used have been reported to be important players in autoimmune 
disorders. Yang et al. [36] reported an increased number of Th22 cells and increased 
serum IL-22 levels in patients with lupus skin disease, but a decrease in patients with 
lupus nephritis. CD62L has been reported to be associated with CD4+CD25brightFOXP3+ 
cells in bullous pemphigoid patients [37]. Finally, expanded clones of CD8+ T 
lymphocytes are present in the lesions of multiple sclerosis [38]. Based on the 
observations from the analyses presented here, our evaluation of CD8+ T cells has 
permitted us to see CD8-subset differences in this cell type in patients diagnosed with 
different uveitides. 
Our ability to study the tradeoff between measuring more parameters or analyzing more 
cells, as shown in Figs. 3(g) and 3(i), has far-reaching consequences for a number of 
emerging technologies that allow for multi-parameter single-cell measurements. For 
more challenging problems than those considered here, it may become necessary to 
study the distributions of the measurement vectors of individual cells rather than its 
principal surrogate of the first moment, and extend the machine learning algorithms to 
well-chosen non-linear kernels. High-throughput automated microscopy, where 
thousands of cells are imaged automatically, is quickly becoming the norm, calling for 
reliable approaches to classify observations and quantify phenotypes. Similarly, while 
simultaneous (multicolor) measurement of 16 parameters is the current state-of-the-art 
for flow cytometry, a next generation of high-throughput single-cell analysis tools is 
emerging that will allow the measurement of more than 50 parameters at comparable 
high throughput by means of mass cytometry [3,4].  It is now also becoming possible to 
analyze gene sequences or gene expression levels for individual cells, although the 
cost of these expensive technologies severely limits the sample size to much fewer cells 
than flow cytometry [5,6]. Optimizing the tradeoff between measuring more cells or more 
parameters, as we demonstrate here, should allow us to take full advantage of these 
powerful and promising next-generation single-cell technologies.
Methods
Ethics Statement:
This investigation was conducted according to the principles expressed in the 
Declaration of Helsinki and was approved by institutional review boards at National Eye 
Institute, National Institutes of Health. The written informed consent was provided by all 
patients.
For the study of Hutchinson-Gilford progeria syndrome, cultured fibroblasts from two 
patients (HGADFN164-p15 and HGADFN167-p15) and two healthy individuals 
(HGADFN090-p15 and HGADFN168-p15) were used. The cells were fed with fresh 
MEM medium containing 15% FBS and grown at 370C. In order to visualize the nuclei, 
we performed immunofluorescence staining of the nuclear membrane with a mouse 
monoclonal antibody raised against lamin A/C. (MAB3211). This antibody has been well 
characterized in HGPS cells and has also been used in studies of other laminopathies. 
Fluorescence images of about 600 nuclei per cell line were taken with a Zeiss 
fluorescence microscope at 400X magnification, as shown in the examples from Figure 
1B. Following the procedure from Driscoll et al (15), a custom-written MATLAB program 
was used to extract nuclear shapes and their properties, such as the number of 
invaginations, the mean curvature, the standard deviation of the curvature, etc. In 
addition to 12 shape measurements, we obtained 3 measurements of the intensity of 
immunofluorescence from lamin A/C associated with each nucleus (the full list of 
measurements is provided in Figure 2C(i). 
For the study of non-infectious uveitides, peripheral blood samples were obtained from 
a cohort of 22 patients, out of which 7 were diagnosed with sarcoidosis, 6 with Behçetʼs 
disease, 1 with retinal vasculitis, while the remaining 8 were healthy controls. 3 different 
marker panels were studied on each sample, each consisting of 2 scattering 
measurements (FSC and SSC) plus 14 or 15 cell surface fluorochromes. Some 
common markers (such as CD3, CD4, CD8, CD27, CD45, and viability) were used on 
all 3 panels and were checked for consistency. Separate analyses have been performed 
on each set of markers in order to find the best prediction accuracy. Two marker panels 
did not lead to accurate sarcoidosis vs Behçetʼs disease phenotypes; the third one, 
which led to an accurate phenotype and has been discussed throughout, consisted of 
FSC, SSC, IL23R, CD196, CD4, viability, CD8, CD27, CD45, IL17A, CD197, CD3, IL22, 
CD62L, CD161, and TNFA. 
Pre-processed datasets are provided as Supporting Information. Multicolor flow 
cytometry raw datasets are available at the Dryad Repository: http://dx.doi.org/10.5061/
dryad.v6st3.
Data analysis was performed using custom-written programs in R and Perl. 
Supporting Information
SI Dataset S1: Nuclear shape and lamin A/C measurements for 2 healthy and 2 HGPS 
cell lines.
SI Dataset S2: Multicolor flow cytometry  (all cells) from 22 patients labeled according to 
disease type or healthy status for a randomized single-cell subsample and for the 
different supercell sizes used in this paper. 
SI Dataset S3: Multicolor flow cytometry (CD4+ T cells) from 22 patients labeled 
according to disease type or healthy  status for a randomized single-cell subsample and 
for the different supercell sizes used in this paper. 
SI Dataset S4: Multicolor flow cytometry (CD8+ T cells) from 22 patients labeled 
according to disease type or healthy  status for a randomized single-cell subsample and 
for the different supercell sizes used in this paper. 
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FIGURE 1: 
Identifying diseases from heterogeneous single cells.  
A. Using standard methods of flow cytometry analysis, diseases such as 
sarcoidosis and Behçetʼs cannot be separated. (i)  2D scatter plot using markers 
CD3 and IL22. (ii) 2D Singular-Value decomposition analysis. Figs. A(i)-(ii) show CD8+ 
T cell subsamples from a cohort of 7 sarcoidosis patients and 6 patients diagnosed with 
Behçetʼs disease, but similar overlaps are also observed for other cell types and marker 
pairs. B. Cell ensembles carry the signatures of health and disease, despite 
heterogeneity at the single-cell level. (i)-(iv) Nuclear shapes of healthy and diseased 
(HGPS) cells can be classified as either blebbed or non-blebbed. Scale bar: 10µ. Note 
that it is impossible to tell whether a person has the disease or not based on the 
analysis of a single cell. (v) Classifying nuclei as blebbed (red) or non-blebbed (black) 
based on just one shape parameter, which is automatically determined via custom 
image analysis software. Most cells in the ensemble of 30 randomly selected nuclei 
from a diseased cell line are labeled as blebbed. Scale bar: 50µ. (vi) Conversely, 
analyzing nuclei from a healthy cell line, most cells are labeled as non-blebbed. 
FIGURE 2: 
Quantitative multiparameter phenotyping of healthy and HGPS cells through cell 
averaging (“supercells”) and machine learning. A. Probability density  distributions 
for one shape parameter (number of invaginations of the nuclear boundary) for healthy 
and diseased cell lines: (i) single cells; (ii)  supercells of size 30. The cell averaging 
procedure removes the overlap between healthy and diseased cell line distributions. B. 
Distance from the perceptron boundary after machine learning, where positive 
(negative) distances correspond to the boundary side identified with the healthy 
(diseased) class: (i) single cells; (ii)  supercells of size 30. Each cell line is shown 
separately along the horizontal axis. C. (i) Perceptron amplitudes: components of the 
vector normal to the classification hyperplane, each one associated with one of the 
shape parameters shown in the list. (ii)  Fraction of cells correctly classified by the 
machine learning process as a function of the supercell size for a varying number of 
parameters used, as indicated. The top M measures are selected from the rank-ordered 
list based on the absolute values of the perceptron amplitudes.  
FIGURE 3:  
Predictive power of automated phenotyping to distinguish healthy vs diseased, or 
sarcoidosis vs Behçetʼs for different cell types and number of markers measured. 
(a)-(f)  A jackknife analysis of patient classification was carried out based on a sample 
with 100 supercells, where each supercell was obtained from averages over 500 
randomly chosen cells. The percentage of patients correctly classified is shown as 
green bars, the percentage of patients for which a classification is not possible (because 
less than 95% of supercells fall into either one of the classes) is shown as blue bars, 
while the percentage of patients incorrectly classified is shown as red bars. The top  10 
measures for each case are listed to the right of each plot. Separate analyses have 
been carried out for all cells, CD4+ T cells and CD8+ T cells, as indicated, as well as for 
the two binary classification scenarios “healthy vs diseased”, and “sarcoidosis vs 
Behçet's”. (g) Percentage of supercells correctly  classified as healthy or diseased, as a 
function of the supercell size and the number of measures used, within the CD4+ T cell 
subpopulation. (h) Distribution of the top  marker (CD27) for supercells averaged over 
500 randomly chosen CD4+ T cells. (i)  Percentage of supercells correctly classified as 
sarcoidosis or Behçetʼs disease, as a function of the supercell size and the number of 
measures used, within the CD8+ T cell subpopulation. (j)  Linear combination of the top 5 
markers IL22, CD3, viability, CD8 and CD62L, as a function of CD3, for supercells 
averaged over 500 randomly chosen CD8+ T cells. 
FIGURE 4:  
Summary of the supercell approach. (a) 2D synthetic data representing 7 single-cell 
patient samples in two categories. Due to cell heterogeneity, different phenotypes 
overlap  and the data are non-separable. (b)  A machine learning approach such as 
support vector machines is able to find the optimal decision boundary between two 
classes of datapoints. However, this method (and variants thereof) fail when the 
samples are strongly overlapping, as is the usual case for single-cell datasets (recall 
Fig. 1A(i)). (c) Sample means or higher-order moments of the cell multivariate 
distributions generally lead to poor, non-robust phenotypes. The solid line is the class 
boundary learnt using all datapoints; by removing either of the support vectors that 
define this boundary  (marked by “I”, “II”, and “III”), the boundary changes as indicated 
by the dashed lines, thus leading to jackknife prediction failures. (d) Representing 
patient samples by supercell distributions, class separation becomes robust. Removing 
patient samples “I”, “II”, or “III”, the decision boundary changes as shown by the dashed 
lines. Departures from the boundary learnt using all patients (solid line) are less 
significant and do not cause any jackknife failed predictions.        
